Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 69932243 | 6993224 | 3 | F | 2009 | 20160622 | 20090513 | 20160705 | EXP | US-BAYER-200920329NA | BAYER | 24.00 | YR | A | F | Y | 81.63000 | KG | 20160705 | OT | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 69932243 | 6993224 | 1 | PS | MIRENA | LEVONORGESTREL | 1 | Intra-uterine | CONTINUOUS | 21225 | 20 | UG | INTRAUTERINE DELIVERY SYSTEM |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 69932243 | 6993224 | 1 | Contraception |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 69932243 | 6993224 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 69932243 | 6993224 | Device use issue | |
| 69932243 | 6993224 | Headache | |
| 69932243 | 6993224 | Infection | |
| 69932243 | 6993224 | Pain | |
| 69932243 | 6993224 | Pyrexia | |
| 69932243 | 6993224 | Somatic symptom disorder | |
| 69932243 | 6993224 | Uterine perforation |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 69932243 | 6993224 | 1 | 20070529 | 20090519 | 0 |